Profil
Dr. Jean Zetlaoui is an Independent Member-Supervisory Board at Valbiotis SA and a Vice President at Alliance for Research & Innovation in Health Industries.
He is on the Board of Directors at Valbiotis SA and Pharcor SAS. Dr. Zetlaoui was previously employed as a Scientific Director by Novartis Pharma SAS, a Chief Medical Officer by Nestle Health Science SA, and a Head-Global Regulatory & Medical Affairs by Sanofi-Aventis SA. He received his MBA from ESSEC Business School.
Postes actifs de Jean Zetlaoui
| Sociétés | Poste | Début |
|---|---|---|
| VALBIOTIS | Directeur/Membre du Conseil | 26/10/2017 |
Alliance for Research & Innovation in Health Industries | Corporate Officer/Principal | - |
Pharcor SAS
Pharcor SAS MiscellaneousMiscellaneous Functions as an investment holding company | Directeur/Membre du Conseil | 19/02/2021 |
Anciens postes connus de Jean Zetlaoui
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Directeur Technique/Scientifique/R&D | 01/06/2019 |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Directeur Technique/Scientifique/R&D | 01/12/2013 |
| SANOFI | Directeur Technique/Scientifique/R&D | 01/11/2010 |
Formation de Jean Zetlaoui
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharcor SAS
Pharcor SAS MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
Alliance for Research & Innovation in Health Industries | |
Valbiotis SA
Valbiotis SA BiotechnologyHealth Technology Operates as a research and development platform to discover & develop polymolecular complexes | Health Technology |
















